vs
Side-by-side financial comparison of dLocal Ltd (DLO) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
dLocal Ltd is the larger business by last-quarter revenue ($337.9M vs $185.2M, roughly 1.8× AMICUS THERAPEUTICS, INC.). dLocal Ltd runs the higher net margin — 16.5% vs 0.9%, a 15.6% gap on every dollar of revenue. On growth, dLocal Ltd posted the faster year-over-year revenue change (65.2% vs 23.7%). dLocal Ltd produced more free cash flow last quarter ($99.8M vs $16.0M).
dLocal Limited is a Uruguayan financial technology company. It provides cross-border payments connecting global merchants to emerging markets.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
DLO vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $337.9M | $185.2M |
| Net Profit | $55.6M | $1.7M |
| Gross Margin | 34.3% | 85.7% |
| Operating Margin | 18.6% | 8.6% |
| Net Margin | 16.5% | 0.9% |
| Revenue YoY | 65.2% | 23.7% |
| Net Profit YoY | 87.3% | -88.5% |
| EPS (diluted) | $0.18 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $337.9M | $185.2M | ||
| Q3 25 | $282.5M | $169.1M | ||
| Q2 25 | — | $154.7M | ||
| Q1 25 | — | $125.2M | ||
| Q4 24 | $204.5M | $149.7M | ||
| Q3 24 | $185.8M | $141.5M | ||
| Q2 24 | — | $126.7M | ||
| Q1 24 | — | $110.4M |
| Q4 25 | $55.6M | $1.7M | ||
| Q3 25 | $141.3M | $17.3M | ||
| Q2 25 | — | $-24.4M | ||
| Q1 25 | — | $-21.7M | ||
| Q4 24 | $29.7M | $14.7M | ||
| Q3 24 | $90.8M | $-6.7M | ||
| Q2 24 | — | $-15.7M | ||
| Q1 24 | — | $-48.4M |
| Q4 25 | 34.3% | 85.7% | ||
| Q3 25 | 36.5% | 88.5% | ||
| Q2 25 | — | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | 40.9% | 90.1% | ||
| Q3 24 | 42.1% | 90.6% | ||
| Q2 24 | — | 91.1% | ||
| Q1 24 | — | 87.7% |
| Q4 25 | 18.6% | 8.6% | ||
| Q3 25 | 19.7% | 20.3% | ||
| Q2 25 | — | -6.1% | ||
| Q1 25 | — | -6.3% | ||
| Q4 24 | 20.7% | 10.7% | ||
| Q3 24 | 22.1% | 15.3% | ||
| Q2 24 | — | 11.8% | ||
| Q1 24 | — | -25.1% |
| Q4 25 | 16.5% | 0.9% | ||
| Q3 25 | 50.0% | 10.2% | ||
| Q2 25 | — | -15.8% | ||
| Q1 25 | — | -17.3% | ||
| Q4 24 | 14.5% | 9.8% | ||
| Q3 24 | 48.9% | -4.8% | ||
| Q2 24 | — | -12.4% | ||
| Q1 24 | — | -43.9% |
| Q4 25 | $0.18 | $0.00 | ||
| Q3 25 | $0.17 | $0.06 | ||
| Q2 25 | — | $-0.08 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | $0.09 | $0.05 | ||
| Q3 24 | $0.09 | $-0.02 | ||
| Q2 24 | — | $-0.05 | ||
| Q1 24 | — | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $719.9M | $293.5M |
| Total DebtLower is stronger | $86.7M | $392.7M |
| Stockholders' EquityBook value | $569.4M | $274.2M |
| Total Assets | $1.5B | $949.9M |
| Debt / EquityLower = less leverage | 0.15× | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $719.9M | $293.5M | ||
| Q3 25 | $604.5M | $263.8M | ||
| Q2 25 | — | $231.0M | ||
| Q1 25 | — | $250.6M | ||
| Q4 24 | $425.2M | $249.9M | ||
| Q3 24 | $560.5M | $249.8M | ||
| Q2 24 | — | $260.1M | ||
| Q1 24 | — | $239.6M |
| Q4 25 | $86.7M | $392.7M | ||
| Q3 25 | $63.1M | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | $39.8M | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | $569.4M | $274.2M | ||
| Q3 25 | $504.7M | $230.4M | ||
| Q2 25 | — | $204.3M | ||
| Q1 25 | — | $193.6M | ||
| Q4 24 | $489.0M | $194.0M | ||
| Q3 24 | $457.0M | $178.8M | ||
| Q2 24 | — | $132.5M | ||
| Q1 24 | — | $130.7M |
| Q4 25 | $1.5B | $949.9M | ||
| Q3 25 | $1.4B | $868.8M | ||
| Q2 25 | — | $815.3M | ||
| Q1 25 | — | $789.8M | ||
| Q4 24 | $1.2B | $785.0M | ||
| Q3 24 | — | $786.6M | ||
| Q2 24 | — | $749.5M | ||
| Q1 24 | — | $721.8M |
| Q4 25 | 0.15× | 1.43× | ||
| Q3 25 | 0.12× | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | 0.08× | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $100.4M | $16.3M |
| Free Cash FlowOCF − Capex | $99.8M | $16.0M |
| FCF MarginFCF / Revenue | 29.5% | 8.6% |
| Capex IntensityCapex / Revenue | 0.2% | 0.2% |
| Cash ConversionOCF / Net Profit | 1.80× | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $378.7M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $100.4M | $16.3M | ||
| Q3 25 | $315.0M | $35.7M | ||
| Q2 25 | — | $-26.5M | ||
| Q1 25 | — | $7.8M | ||
| Q4 24 | $-141.1M | $-3.9M | ||
| Q3 24 | $108.3M | $-23.0M | ||
| Q2 24 | — | $22.7M | ||
| Q1 24 | — | $-29.7M |
| Q4 25 | $99.8M | $16.0M | ||
| Q3 25 | $313.4M | $35.3M | ||
| Q2 25 | — | $-28.9M | ||
| Q1 25 | — | $7.5M | ||
| Q4 24 | $-141.6M | $-4.2M | ||
| Q3 24 | $107.1M | $-23.3M | ||
| Q2 24 | — | $21.6M | ||
| Q1 24 | — | $-31.5M |
| Q4 25 | 29.5% | 8.6% | ||
| Q3 25 | 110.9% | 20.9% | ||
| Q2 25 | — | -18.7% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | -69.2% | -2.8% | ||
| Q3 24 | 57.6% | -16.5% | ||
| Q2 24 | — | 17.0% | ||
| Q1 24 | — | -28.5% |
| Q4 25 | 0.2% | 0.2% | ||
| Q3 25 | 0.6% | 0.2% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | 0.2% | 0.2% | ||
| Q3 24 | 0.7% | 0.3% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | 1.80× | 9.62× | ||
| Q3 25 | 2.23× | 2.06× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -4.75× | -0.27× | ||
| Q3 24 | 1.19× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DLO
Segment breakdown not available.
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
